Gene expression profiling predicts clinical outcome of breast cancer
Laura Van 't VeerDivisions of Diagnostic Oncology, Radiotherapy and Molecular Carcinogenesis and Center for Biomedical Genetics, The Netherlands Cancer Institute, 121 Plesmanlaan, 1066 CX Amsterdam, The NetherlandsHongyue DaiDepartment of Adult Oncology, Dana-Farber Cancer Institute and Department of Medicine, Harvard Medical School, Boston, Massachusetts 02115, USAMarc Van De VijverDepartment of Adult Oncology, Dana-Farber Cancer Institute and Department of Medicine, Harvard Medical School, Boston, Massachusetts 02115, USAYudong HeAugustinus HartDivisions of Diagnostic Oncology, Radiotherapy and Molecular Carcinogenesis and Center for Biomedical Genetics, The Netherlands Cancer Institute, 121 Plesmanlaan, 1066 CX Amsterdam, The NetherlandsMao MaoHans PeterseRosetta Inpharmatics, 12040 115th Avenue NE, Kirkland, Washington 98034, USAKarin Van Der KooyCenter for Neurologic Diseases, Department of Neurology, Brigham and Women's Hospital and Harvard Medical School; andMatthew MartonAnke WitteveenCenter for Neurologic Diseases, Department of Neurology, Brigham and Women's Hospital and Harvard Medical School; andGeorge SchreiberRon KerkhovenRosetta Inpharmatics, 12040 115th Avenue NE, Kirkland, Washington 98034, USAChris RobertsPeter LinsleyRene BernardsRosetta Inpharmatics, 12040 115th Avenue NE, Kirkland, Washington 98034, USAStephen FriendLaurent MonneyRosetta Inpharmatics, 12040 115th Avenue NE, Kirkland, Washington 98034, USACatherine SabatosDivisions of Diagnostic Oncology, Radiotherapy and Molecular Carcinogenesis and Center for Biomedical Genetics, The Netherlands Cancer Institute, 121 Plesmanlaan, 1066 CX Amsterdam, The NetherlandsJason GagliaDivisions of Diagnostic Oncology, Radiotherapy and Molecular Carcinogenesis and Center for Biomedical Genetics, The Netherlands Cancer Institute, 121 Plesmanlaan, 1066 CX Amsterdam, The NetherlandsAkemi RyuDivisions of Diagnostic Oncology, Radiotherapy and Molecular Carcinogenesis and Center for Biomedical Genetics, The Netherlands Cancer Institute, 121 Plesmanlaan, 1066 CX Amsterdam, The NetherlandsHanspeter WaldnerRosetta Inpharmatics, 12040 115th Avenue NE, Kirkland, Washington 98034, USATatyana ChernovaMillennium Pharmaceuticals, 640 Memorial Drive, Cambridge, Massachusetts 02139, USAStephen ManningEdward GreeneldCenter for Neurologic Diseases, Department of Neurology, Brigham and Women's Hospital and Harvard Medical School; andAnthony CoyleRaymond SobelGordon FreemanDepartment of Adult Oncology, Dana-Farber Cancer Institute and Department of Medicine, Harvard Medical School, Boston, Massachusetts 02115, USAVijay KuchrooDivisions of Diagnostic Oncology, Radiotherapy and Molecular Carcinogenesis and Center for Biomedical Genetics, The Netherlands Cancer Institute, 121 Plesmanlaan, 1066 CX Amsterdam, The NetherlandsW McguireA GoldhirschJ GlickR GelberH SennP EifelEarly BreastCancer TrialistsCollaborative GroupEarly BreastCancer TrialistsCollaborative GroupC PerouC PerouS GruvbergerK MartinD ZajchowskiT SorlieM WestT HughesC RobertsS LakhaniJ BrentonS AparicioC CaldasJ KhanY HeS FriendI BiecheP SteegQ ZhouF JanickeP Van DiestL ZhengL AnnabC AfshariW LeeT BoyerM EstellerM ChapmanI VermaI Hedenfalk
2002en
ABI
Annotatsiya
Annotatsiya mavjud emas.
Identifikatorlar
Iqtiboslar va manbalar
2 ta iqtibos0 ta foydalanilgan manba